India and Vietnam Near BrahMos Missile Deal Implications for Defense Sector and Regional Security RBIs 5 Billion FX Swap Nearly Doubly Subscribed as Central Bank Steps Up Rupee Defense Kazatomprom Reports 17 Production Increase in Q3 Bolstering Uranium Supply Outlook Three Signs from APEC Highlight Persistent USChina Trade Divide Perpetua Resources Secures 29 Billion Loan from US ExportImport Bank Texas Accountant Allegedly Embezzles 3 Million From Employer Funding Luxury Lifestyle Unisys Corporation UIS Q1 2026 Earnings EPS Surges Past Estimates Restructuring Gains Traction SL Green Realty Corp Q1 2026 Earnings Significant EPS Miss Amidst Market Headwinds NTLA Q1 2026 Earnings NarrowerThanExpected Loss Fuels Optimism in Gene Editing Pipeline VLYPP Q1 2026 Earnings Preferred EPS Beats Estimates Stock Declines Slightly Loop Industries Q1 2026 Earnings Narrowing Losses as Company Advances Depolymerization Technology Arteris Inc Q1 2026 Earnings Narrower Loss Beats Estimates as Cost Discipline Improves Sonos SONO Rallies 348 as Shares Approach Key Resistance MGRE Junior Subordinated Notes Edge Higher Key Support and Resistance Levels in Focus Xsolla SPAC 1 XSLL Holds Steady at 990 as Market Awaits Catalysts Lionheart Holdings Warrant CUBWW Holds Steady at 017 Amid Narrow Trading Range Cardiol Therapeutics Inc CRDL Modestly Advances as It Holds Above Key Support BWIN Q1 2026 Earnings EPS Misses Estimates Amid Operating Headwinds ATLN Q4 2025 Earnings Significant EPS Miss Weighs on Stock RenaissanceRe Holdings Ltd RNR Q1 2026 Earnings Strong Underwriting Drives EPS Beat of 23 ADAMN Q1 2026 Earnings Strong EPS Surprise of 75 Despite Modest Stock Pullback GRCE Q1 2026 Earnings EPS Surprises to the Upside Despite No Revenue Immunome Inc Q1 2026 Earnings NarrowerThanExpected Loss Amid No Revenue Stock Slips Amazon Expands AI Shopping Technology to ThirdParty Retailers Signs Kate Spade as First Customer Saratoga Investment Corp 8125 Notes due 2027 SAY Q1 2026 Earnings Steep EPS Miss Weighs on Sentiment Despite Modest Price Recovery Protagonist Therapeutics PTGX Hovering Near Resistance After Modest Pullback